2026-09-04
Undisclosed of new funding is targeting drug discovery and research informatics
1 funded company building into drug discovery and research informatics. The work in scope is what the Head of Research Informatics owns today.
The funding
Mandrake Bio is building AI-native protein design and gene editing infrastructure to turn biology from discovery into engineering.
Mandrake Bio Raises ₹16 Crore To Advance AI-Driven Gene Editing →What it means
Capital arriving in a function is a reliable leading indicator. It does not mean the incumbents are wrong, and it does not mean these companies will succeed. It means that within the next few quarters the people who run this work will be asked what their function is doing about it, and the honest answer has to start with where that function actually stands.
So we built the assessment for it. Not a purchase decision, a structured set of questions to take to your own team.